Pharmig’s 34th Annual Conference

Pharmig’s 34th Annual Conference – 3rd & 4th November 2026
Hot Topics in Pharmaceutical Microbiology
NEW VENUE: Chesford Grange Hotel, Kenilworth

Member Fee £995 (Join Now) / Non-Member Fee £1355

DRAFT AGENDA
Outline current confirmed speakers and presentation summary
Note – presentations have not yet been put in order on the programme agenda

1. Regulatory updates addressing steriles and non-steriles – Either the MHRA or Pharmig Committee Members (TBC)
2. Contamination control strategy (CCS) for low bioburden production (bullet points TBC) – Debbie Allen – Associate Director, GSK
3. From days to minutes: Validating flow cytometry for pharmaceutical water monitoring – Marcel Goverde – Managing Director, MGP Consulting GmbH & BWT (Speaker TBC)
4. Novel approaches to material transfer – Andrew Gravett – Principal Scientist, Microbiology PT&D, AstraZeneca
5. Not all bugs are Equal: Designing better micro decisions under uncertainty – Valerie Mullholland – Principal Consultant, GMP Services Ltd
6. Beyond the pass result: How to design, challenge and interpret outsourced disinfectant efficacy studies for GMP contamination control – Sean Lloyd – Founder & Principal Consultant, SRL Pharma and David Collins – Principal Global Technical Consultant Microbiology, Ecolab Technical Consultant
7. CCS: Critical factors that influence environmental monitoring reliability – Providing actionable insights to support more reliable, compliant, and efficient environmental monitoring programs- Peter Penn – Director, NaughtonPenn Consultants
8. Aflatoxin considerations in non-sterile products – Karen Capper – Senior Director, Microbiology Science & Technology, AstraZeneca
9. Automated contamination control for cleanrooms – Dr. Michel Schmidt – CEO, Spectral Blue
10. The challenges of ATCC (American Type Culture Collection) in maintaining their culture collection – Wan Li Low – Distribution Specialist, ATCC
11. Pyrogenicity risk assessments – Professor Tim Sandle – Professor of Pharmaceutical Microbiology and Sterility Assurance, UCL and Pharmig Committee Member
12. Bacterial nomenclature and its impact on the pharmaceutical industry – Marie-Laurence Baille – Senior Microbiology Specialist, MSD Netherlands (TBC) & Miriam Guest – Executive Director & Scientific Advisor, Charles River Laboratories

Additional information
Please click on this link to view the full, current draft agenda and booking form etc.